(Total Views: 347)
Posted On: 07/14/2021 9:08:28 PM
Post# of 86157
Hi DJ - A friend was telling me about the work they are doing for Alzheimer patients,
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has commenced the development of its next-generation patent pending psychedelic drug formulation for the treatment of Alzheimer’s Disease (“Alzheimer’s”).
Could this company or and it’s subsidiary be affiliated with Bioremedies? Psychedelics are huge right now
And not going anywhere… seams to be inline with Doc’s plan?
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has commenced the development of its next-generation patent pending psychedelic drug formulation for the treatment of Alzheimer’s Disease (“Alzheimer’s”).
Could this company or and it’s subsidiary be affiliated with Bioremedies? Psychedelics are huge right now
And not going anywhere… seams to be inline with Doc’s plan?
(10)
(0)Scroll down for more posts ▼
